Nrf2 is involved in inhibiting Tat-induced HIV-1 long terminal repeat transactivation. [electronic resource]
- Free radical biology & medicine Aug 2009
- 261-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1873-4596
10.1016/j.freeradbiomed.2009.04.028 doi
Acetylcysteine--pharmacology Active Transport, Cell Nucleus--drug effects Buthionine Sulfoximine--pharmacology Cell Nucleus--metabolism Enzyme Inhibitors--pharmacology Gene Expression Regulation, Viral Glutathione--metabolism HIV Infections--genetics HIV-1--physiology HeLa Cells Humans Intracellular Signaling Peptides and Proteins--genetics Kelch-Like ECH-Associated Protein 1 NF-E2-Related Factor 2--genetics RNA, Small Interfering--genetics Reactive Oxygen Species Terminal Repeat Sequences--genetics Transcriptional Activation--drug effects Virus Replication--drug effects tat Gene Products, Human Immunodeficiency Virus--metabolism